StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

Bullboard Posts

Comment by HollywoodHusson May 26, 2020 10:29am

113 Views

Post# 31072745

RE:RE:Aristotle - MULTI CANCER PLATFORM ! This is our FUTURE !

The question is though. If our tests are so blatant obvious of positive or negative and so accurate. How do the main government heads not use this as the "Go To" test if it's the dream test. I haven't heard about SZLS anywhere on media or television for testing. Why is it not more popular and talked about by health experts to use SZLS testing if it's such a perfect test which I believe it is.

Bullboard Posts

Options trading in a volatile macro environment